It was observed that while the 4T1 model necessitated the administration of all six agents (hexatherapy regimen) to decrease the overall tumor burden (figure 7A), significant tumor control of MC38-CEA could be achieved using a combination of two IO agents (figure 2H). This evidence concerns the gene CEACAM5 and neoplasm.